From Science 2.0 to Pharma 3.0

1st Edition

Semantic Search and Social Media in the Pharmaceutical industry and STM Publishing

Print ISBN: 9781843347095
eBook ISBN: 9781780633756
Imprint: Chandos Publishing
Published Date: 10th September 2012
Page Count: 286
65.95 + applicable tax
52.50 + applicable tax
85.00 + applicable tax
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered. This title is divided into three parts. The first part considers the Web 2.0 revolution, and the promise of its impact on science communication and the state of Science 2.0. The second part looks at impact on Pharma and Health, including attempts to utilise digital in Pharma. The last part looks at the promising disruptive technologies of Web 3.0, including semantic search in biomedicine and enterprise platforms. The book concludes by looking forward to developments of ‘3.0’ in Pharma and STM publishing.

Key Features

  • Gives a global overview of success and failure in Science 2.0
  • Presents useful stories and lessons learned
  • Gives a clear view of how semantic search is present in science platforms and its potential in STM publishing


Those interested in Science 2.0 and Pharma 3.0., including researchers, information professionals, and managers

Table of Contents

List of figures

List of abbreviations


About the authors


Part 1: From Science 2.0 (2000–2010) …


Chapter 1: The Web 2.0 revolution and the promise of Science 2.0


The web as a platform: web services, the cloud and the app

Harnessing collective intelligence

Data as the ‘next Intel Inside’

Chapter 2: The state of Science 2.0


A reluctance to change

Scepticism about the promise of Science 2.0

The lack of a supportive environment


Part 2: … and Pharma 2.0 …


Chapter 3: Health 2.0 and beyond


2.0 becomes social media

Big promises: is there a pot of gold?

Leading Health 2.0 and social media sites and applications

Chapter 4: The digital pharma industry


The pharma industry adopts …

The pharma industry watches …

The pharma industry remains cautious: the dark face of SoMe

Part 3: … to Pharma 3.0 (2010–)


Chapter 5: The semantic search in life sciences


Semantic? What’s this?

What do researchers expect?

A survey of biomedical semantic interfaces

The future will be semantic

The semantic for pharmas

Chapter 6: Enterprise 2.0 and Web 3.0


Enterprise 2.0

MS SharePoint 2010

And the next revolutions are?


Chapter 7: The next 3.0


Science 3.0

Pharma 3.0

Big STM 3.0





No. of pages:
© Chandos Publishing 2012
Chandos Publishing
eBook ISBN:
Paperback ISBN:


"In this work the authors highlight the added potential of cloud computing and publishing in an evolving and dynamic context. Success stories, as well as problems experienced, are shared. Although focusing on the pharmaceutical industry, the wider context of science, technology and medicine (STM) also features."--Online Information Review, Vol. 37 No. 6, 2013

I can only highly recommend reading this book by Hervé Basset for a better understanding of the challenges of social media., Jean-Philippe Accart
I was impressed by the team of authors who worked on the book. Their knowledge of the subject and understanding of the respective industries, as well as the level of control of vast literature and information is very impressive., Information Research
As a librarian in a large pharmaceutical company, Hervé Bassett has a perspective both on drug manufacturers and consumers of scientific information., Information Today